LUNAPHORE
LIVE

Serial Number

79179383

Owner

Lunaphore Technologies SA

Attorney

Courtney Thompson

Filing Date

Nov 6, 2015

Add to watchlist:

No watchlists yet
View on USPTO

LUNAPHORE Trademark

Serial Number: 79179383 • Registration: 5361858

LUNAPHORE is a trademark filed by Lunaphore Technologies SA on November 6, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Lunaphore Technologies SA (7 trademarks)

Route de Lully 5C

Entity Type: 33

Trademark Details

Filing Date

November 6, 2015

Registration Date

December 26, 2017

Published for Opposition

October 10, 2017

Goods & Services

Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms; optical apparatus and instruments, namely, microscopes, optical profilers, optical filters, optical glasses, optical lens sights, optical scanners, optical readers, optical reflectors; [ weighing apparatus and instruments, namely, scales and balances; ] measuring apparatus and instruments, namely, instruments for measuring the quantity of contaminants, pollutants, or malignant cells in human, animal, plant, or microorganism cells and tissues; signaling apparatus and instruments, namely, signal processors, and signal splitters for electronic apparatus; measuring and testing machines and instruments, namely, digitizers; laboratory apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; microfluidic testing apparatus not for medical purposes in the form of assay chips, biological assay chips, and sample processing chips; microfluidic systems, namely, sample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubes, reservoirs, pumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidics, not for medical purposes used to diagnose cancer; chips, namely, integrated circuits; microfluidic chips in the nature of integrated circuits; [ DNA chips; ] biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chips, namely, microchips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatus, instruments and devices, namely, calculating machines, central processing units and computers for the input, output, transmission, storage, and processing of data, in particular scientific and medical data; Software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms collected via immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing

Medical apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing using fluid technology; diagnostic apparatus for medical purpose; microfluidic testing apparatus for medical purposes for testing biomarker expression levels in cell and tissue samples

Diagnostic substances, preparations and agents for medical purposes; diagnostic reagents [ and contrast media ] for medical purposes; [ contrast media for use with medical equipment; ] diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical purposes; diagnostic test reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids [; biotechnological preparations for medical purposes for the treatment of cancer and metabolic diseases ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 7, 2025 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 21, 2025 INPS
INVALIDATION PROCESSED
Sep 20, 2025 INPC
INTERNATIONAL REGISTRATION RENEWED
Jun 5, 2025 RNWL
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 18, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 18, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 18, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 16, 2024 APRE
TEAS SECTION 71 RECEIVED
Dec 22, 2023 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Nov 10, 2023 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 6, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 6, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 6, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 6, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 6, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 6, 2023 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 26, 2022 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 5, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 5, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 5, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 5, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 5, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 5, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 5, 2022 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 27, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 19, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 2, 2018 FICS
FINAL DISPOSITION PROCESSED
Apr 2, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 26, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 26, 2017 R.PR
NOTIFICATION PROCESSED BY IB
Nov 17, 2017 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 10, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 10, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 20, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 20, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 5, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 15, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 15, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 15, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 15, 2017 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 8, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 21, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 21, 2017 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 14, 2017 GNFN
FINAL REFUSAL E-MAILED
Apr 14, 2017 GNFR
FINAL REFUSAL WRITTEN
Apr 14, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2016 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2016 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2016 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 26, 2016 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2016 CRFA
ASSIGNED TO LIE
Sep 2, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2016 TROA
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Aug 18, 2016 CREV
REFUSAL PROCESSED BY IB
Mar 26, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 8, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 5, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 4, 2016 CNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2016 CNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2016 DOCK
CORRECTION TRANSACTION RECEIVED FROM IB
Jan 22, 2016 CRCV
APPLICATION FILING RECEIPT MAILED
Jan 5, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 30, 2015 REPR